Cargando…

All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease

Detalles Bibliográficos
Autor principal:	Stein, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935728/ https://www.ncbi.nlm.nih.gov/pubmed/32601777 http://dx.doi.org/10.1007/s10620-020-06429-6

Ejemplares similares

Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
por: Jung, Yoon Suk
Publicado: (2020)

Reduce Acute Care Costs, and All Other Healthcare Costs Too
por: Weintraub, William S.
Publicado: (2019)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Reconsidering axillary surgery for early breast cancer
por: Jatoi, Ismail
Publicado: (2017)

Pulmonary metastasectomy—is the extent of resection worth reconsidering?
por: Krüger, Marcus, et al.
Publicado: (2022)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Reconsidering the Nomenclature of Irreversible Pulpitis: A Call for Change
por: Eghbal, Mohammad Jafar, et al.
Publicado: (2023)

Reconsidering patient‐centred care: Authority, expertise and abandonment
por: Pilnick, Alison
Publicado: (2023)

Didn’t inhale? Time to reconsider aerosolized antibiotics in the treatment of ventilator-associated pneumonia
por: Sweeney, Daniel A., et al.
Publicado: (2018)

Costs in inflammatory bowel diseases
por: Petryszyn, Paweł W., et al.
Publicado: (2016)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Race and Inflammatory Bowel Disease in an Urban Healthcare System
por: Sewell, Justin L., et al.
Publicado: (2010)

Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
por: Daskalakis, Kosmas, et al.
Publicado: (2018)

Unexpected Discoveries Should Be Reconsidered in Science—A Look to the Past?
por: Foletti, Alberto, et al.
Publicado: (2019)

All systems are go
por: Eyers, Claire E, et al.
Publicado: (2008)

All systems go
por: Powell, Kendall
Publicado: (2004)

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
por: Setyawan, Juliana, et al.
Publicado: (2021)

The Whiplash Disease Reconsidered
por: Astrup, Jens, et al.
Publicado: (2022)

Choosing a Second Biologic Agent for Inflammatory Bowel Disease Patients—Cost Considerations and Clinical Outcomes
por: Clarke, Kofi
Publicado: (2020)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
por: de Carvalho, Antonelly Cassio Alves, et al.
Publicado: (2020)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Screening for colorectal cancer in patients with inflammatory bowel disease. Should we already perform chromoendoscopy in all our patients?
por: Huguet, Jose María, et al.
Publicado: (2018)

Optimizing cost-efficiency in mean exposure assessment - cost functions reconsidered
por: Mathiassen, Svend Erik, et al.
Publicado: (2011)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Quality of life in inflammatory bowel diseases: it is not all about the bowel
por: Keller, Ronald, et al.
Publicado: (2021)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

A Performance Management System in Healthcare for All Seasons?
por: Vainieri, Milena, et al.
Publicado: (2020)

Reconsidering the Role of Routine Anticoagulation for Venous Thromboembolism Prevention in Plastic Surgery
por: Swanson, Eric
Publicado: (2020)

Is it time to reconsider the need for bullectomy in the surgical management of primary spontaneous pneumothorax?
por: Ali, Jason M., et al.
Publicado: (2020)

Deep Brain Stimulation for Chronic Pain: Time to Reconsider the Skeptical Attitude?
por: Slavin, Konstantin V., et al.
Publicado: (2020)

Patients or prisoners? Time to reconsider the voting rights of mentally disordered offenders
por: Rees, Gareth, et al.
Publicado: (2016)

Should the Definition of Metabolic Syndrome be Reconsidered from the Aspect of Arterial Stiffness?
por: Shirai, Kohji
Publicado: (2022)

Reconsidering Genetic Testing for Neonatal Polycystic Kidney Disease
por: VanNoy, Grace E., et al.
Publicado: (2020)

All Is Not Normal in “Normoganglionic” Bowel Regions of Hirschsprung Disease Model Mice
por: Young, Heather M.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_am412hla4sfjkrn3g9ikpqs3op